Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling
What this study shows
Explains how low oxygen turns mTORC1 off. Growth factors keep TSC2 bound to inhibitory 14-3-3 proteins; under hypoxia REDD1 releases TSC2 from 14-3-3, which frees TSC2 to inhibit mTORC1. REDD1-null cells failed to release TSC2 or to switch mTORC1 off in hypoxia, and REDD1 mutants that cannot bind 14-3-3, or TSC2 mutants that cannot bind it, broke the signal. REDD1-null cells grew into far larger tumours in mice, and REDD1 was low in a subset of human breast carcinomas (8 of 27). Boundary: cell lines and mouse xenografts under acute hypoxia (hours); the human data are expression correlations only.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: REDD1-/- and TSC2-/- mouse embryonic fibroblasts, human cell lines in 1% O2; xenografts in nude mice; human breast carcinoma samples) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | REDD1-/- and TSC2-/- mouse embryonic fibroblasts, human cell lines in 1% O2; xenografts in nude mice; human breast carcinoma samples |
| Journal | Genes & Development |
| Year | 2008 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1101/gad.1617608 · PMID 18198340 · Free full text (PMC2192757) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Hypoxia (1% O2); REDD1 and TSC2 knockout and 14-3-3-binding mutants |
| Target | REDD1 -> TSC2/14-3-3 -> mTORC1 |
| Model | Mouse embryonic fibroblasts, human cell lines, nude-mouse xenografts, human tumour samples |
| Effect | Hypoxia inhibits mTORC1 by REDD1-driven release of TSC2 from 14-3-3; REDD1 loss promotes tumour growth |
In the Atlas
Related topics
Links in the pathway map
- Supports REDD1 (DDIT4) activates TSC1/TSC2
- Supports TSC1/TSC2 inhibits mTORC1
More studies on this topic
- Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex (2004)
- ATF4 activates a transcriptional program that chronically suppresses mTOR activity and promotes neurodegeneration in Parkinson disease models (2026)
- Role of Autophagy in Scleral Remodeling During Form-Deprivation Myopia (2026)
- TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth (2006)
Thank you. Your answer was counted anonymously.